Skip to main content

Peer Review reports

From: Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

Original Submission
24 Jul 2019 Submitted Original manuscript
13 Dec 2019 Reviewed Reviewer Report - Alessandro Russo
26 Dec 2019 Reviewed Reviewer Report - Xiaoqian Zhang
4 Jan 2020 Reviewed Reviewer Report - Adrianus J de Langen
12 Mar 2020 Author responded Author comments - Kang Qin
26 Mar 2020 Author responded Author comments - Kang Qin
Resubmission - Version 2
12 Mar 2020 Submitted Manuscript version 2
Publishing
30 Mar 2020 Editorially accepted
16 Apr 2020 Article published 10.1186/s12885-020-06805-5

You can find further information about peer review here.

Back to article page